Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Codiak BioSciences, Inc.CDAK · Entity 114958 | Director | February 16, 2023 | February 21, 2023 |
| Evelo Biosciences, Inc.EVLO · Entity 108468 | Director | June 08, 2023 | June 12, 2023 |
| Kaleido Biosciences, Inc.KLDO · Entity 129745 | Director | June 30, 2021 | July 01, 2021 |
| THERMO FISHER SCIENTIFIC INC.TMO · Entity 2836 | VP & Chief Financial Officer | September 16, 2004 | September 17, 2004 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Codiak BioSciences, Inc.
Report date February 16, 2023 · Filed February 21, 2023
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 15,350 |
Reported balance
After 2023-02-16 transaction · row 1
1 source rowRow 1 · 2023-02-16 · Exercise / conversion · Acquired 8,750 · Balance 15,350 F1: Restricted stock units ("RSUs") convert into common stock on a one-for-one basis. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2023-02-16 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2023-02-16 · Exercise / conversion · Disposed 8,750 · Balance 0 F2: Each RSU represents a contingent right to receive one share of common stock. F3: On February 16, 2022, the reporting person was granted 8,750 RSUs, which vested in full on February 16, 2023. |
Filing footnotes · ownership attribution and instrument terms
F1: Restricted stock units ("RSUs") convert into common stock on a one-for-one basis.
F2: Each RSU represents a contingent right to receive one share of common stock.
F3: On February 16, 2022, the reporting person was granted 8,750 RSUs, which vested in full on February 16, 2023.
Evelo Biosciences, Inc.
Report date June 08, 2023 · Filed June 12, 2023
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $0.11 · Expires 2033-06-08 | Direct | 20,000 |
Reported balance
After 2023-06-08 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2023-06-08 · Grant · Acquired 20,000 · Balance 20,000 F1: The option vests on the earlier of June 8, 2024, and the day immediately prior to the date of the next annual meeting of the Issuer's stockholders occurring after the date of the grant. |
Filing footnotes · ownership attribution and instrument terms
F1: The option vests on the earlier of June 8, 2024, and the day immediately prior to the date of the next annual meeting of the Issuer's stockholders occurring after the date of the grant.
Kaleido Biosciences, Inc.
Report date June 30, 2021 · Filed July 01, 2021
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $7.44 · Expires 2031-06-29 | Direct | 15,000 |
Reported balance
After 2021-06-30 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2021-06-30 · Grant · Acquired 15,000 · Balance 15,000 |
THERMO FISHER SCIENTIFIC INC.
Report date September 16, 2004 · Filed September 17, 2004
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 158,199 |
Ending reported balance
After 2004-09-16 transaction · row 3
3 source rows · reconciled sequenceRow 1 · 2004-09-16 · Exercise / conversion · Acquired 3,139 · Balance 134,218 Row 2 · 2004-09-16 · Exercise / conversion · Acquired 46,129 · Balance 180,347 Row 3 · 2004-09-16 · Tax withholding · Disposed 22,148 · Balance 158,199 |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $12.74 · Expires 2004-09-22 | Direct | 0 |
Reported balance
After 2004-09-16 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2004-09-16 · Exercise / conversion · Disposed 3,139 · Balance 0 |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $4.96 · Expires 2006-02-11 | Direct | 0 |
Reported balance
After 2004-09-16 transaction · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · 2004-09-16 · Exercise / conversion · Disposed 46,129 · Balance 0 |
| Common StockSEC Table I · non-derivative | IndirectBy 401(k) | 1,702 |
Reported balance
Holding disclosure · report date 2004-09-16 · row 4
Holding and transaction disclosures are not merged.
1 source rowRow 4 · Balance 1,702 |
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 08, 2023 Filed Jun 12, 2023 16:04 UTC | Evelo Biosciences, Inc. EVLO · Entity 108468 | GrantStock Option (Right to Buy) · Derivative | 20,000 | $0.00 Strike: $0.11 | $0.00 |
DisclosureSEC source: 0001694665-23-000084 · wk-form4_1686600256.xml · derivative · entry 1 MELAS KYRIAZI THEO · CIK 0001216078 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 20,000 shares Expires 2033-06-08 F1 · derivative.exercise_date: The option vests on the earlier of June 8, 2024, and the day immediately prior to the date of the next annual meeting of the Issuer's stockholders occurring after the date of the grant. Read SEC document |
| February 16, 2023 Filed Feb 21, 2023 16:30 UTC | Codiak BioSciences, Inc. CDAK · Entity 114958 | Exercise / conversionRestricted Stock Units · Derivative | 8,750 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-23-005688 · doc4.xml · derivative · entry 2 MELAS KYRIAZI THEO · CIK 0001216078 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 8,750 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of common stock. F3 · derivative.exercise_date: On February 16, 2022, the reporting person was granted 8,750 RSUs, which vested in full on February 16, 2023. F3 · derivative.expiration_date: On February 16, 2022, the reporting person was granted 8,750 RSUs, which vested in full on February 16, 2023. Read SEC document |
| February 16, 2023 Filed Feb 21, 2023 16:30 UTC | Codiak BioSciences, Inc. CDAK · Entity 114958 | Exercise / conversionCommon Stock | 8,750 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-23-005688 · doc4.xml · nonDerivative · entry 1 MELAS KYRIAZI THEO · CIK 0001216078 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,350 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units ("RSUs") convert into common stock on a one-for-one basis. Read SEC document |
| June 17, 2022 Filed Jun 21, 2022 16:47 UTC | Codiak BioSciences, Inc. CDAK · Entity 114958 | GrantRestricted Stock Units · Derivative | 1,500 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-22-023401 · doc4.xml · derivative · entry 2 MELAS KYRIAZI THEO · CIK 0001216078 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,500 Underlying: Common Stock · 1,500 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock. F3 · derivative.exercise_date: On June 17, 2022, the reporting person was granted 1,500 restricted stock units, which shall vest in full upon the earlier to occur of (i) June 17, 2023 and (ii) the Issuer's next annual meeting of stockholders. F3 · derivative.expiration_date: On June 17, 2022, the reporting person was granted 1,500 restricted stock units, which shall vest in full upon the earlier to occur of (i) June 17, 2023 and (ii) the Issuer's next annual meeting of stockholders. Read SEC document |
| June 17, 2022 Filed Jun 21, 2022 16:47 UTC | Codiak BioSciences, Inc. CDAK · Entity 114958 | GrantStock Option (Right to Buy) · Derivative | 7,500 | $0.00 Strike: $2.83 | $0.00 |
DisclosureSEC source: 0000899243-22-023401 · doc4.xml · derivative · entry 1 MELAS KYRIAZI THEO · CIK 0001216078 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,500 Underlying: Common Stock · 7,500 shares Expires 2032-06-16 F1 · derivative.exercise_date: This option shall vest in full upon the earlier to occur of (i) June 17, 2023 and (ii) the Issuer's next annual meeting of stockholders. Read SEC document |
| June 09, 2022 Filed Jun 13, 2022 16:53 UTC | Evelo Biosciences, Inc. EVLO · Entity 108468 | GrantStock Option (Right to Buy) · Derivative | 20,000 | $0.00 Strike: $2.60 | $0.00 |
DisclosureSEC source: 0001694665-22-000108 · wf-form4_165515358545898.xml · derivative · entry 1 MELAS KYRIAZI THEO · CIK 0001216078 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 20,000 shares Expires 2032-06-09 F1 · derivative.exercise_date: The option vests on the earlier of June 9, 2023 and the day immediately prior to the date of the next annual meeting of the Issuer's stockholders occurring after the date of grant. Read SEC document |
| February 16, 2022 Filed Feb 18, 2022 16:05 UTC | Codiak BioSciences, Inc. CDAK · Entity 114958 | GrantRestricted Stock Units · Derivative | 8,750 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-22-007007 · doc4.xml · derivative · entry 1 MELAS KYRIAZI THEO · CIK 0001216078 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,750 Underlying: Common Stock · 8,750 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock. F2 · derivative.exercise_date: On February 16, 2022, the reporting person was granted 8,750 restricted stock units, which vest on the first anniversary of the grant date. F2 · derivative.expiration_date: On February 16, 2022, the reporting person was granted 8,750 restricted stock units, which vest on the first anniversary of the grant date. Read SEC document |
| June 30, 2021 Filed Jul 1, 2021 16:35 UTC | Kaleido Biosciences, Inc. KLDO · Entity 129745 | GrantStock Option (Right to Buy) · Derivative | 15,000 | $0.00 Strike: $7.44 | $0.00 |
DisclosureSEC source: 0001209191-21-044427 · doc4.xml · derivative · entry 1 MELAS KYRIAZI THEO · CIK 0001216078 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,000 Underlying: Common Stock · 15,000 shares Expires 2031-06-29 Read SEC document |
| June 18, 2021 Filed Jun 22, 2021 19:08 UTC | Codiak BioSciences, Inc. CDAK · Entity 114958 | GrantStock Option (Right to Buy) · Derivative | 10,000 | $0.00 Strike: $24.13 | $0.00 |
DisclosureSEC source: 0000899243-21-025388 · doc4.xml · derivative · entry 1 MELAS KYRIAZI THEO · CIK 0001216078 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 10,000 shares Expires 2031-06-17 F1 · derivative.exercise_date: This option shall vest in full upon the earlier to occur of (i) June 18, 2022, or (ii) the next annual meeting of the Issuer's stockholders. Read SEC document |
| June 09, 2021 Filed Jun 11, 2021 16:07 UTC | Evelo Biosciences, Inc. EVLO · Entity 108468 | GrantStock Option (Right to Buy) · Derivative | 1,810 | $0.00 Strike: $14.19 | $0.00 |
DisclosureSEC source: 0001694665-21-000087 · wf-form4_162344202848304.xml · derivative · entry 2 MELAS KYRIAZI THEO · CIK 0001216078 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,810 Underlying: Common Stock · 1,810 shares Expires 2031-06-08 F1 · derivative.exercise_date: The option vests on the earlier of June 8, 2022 and the day immediately prior to the date of the next annual meeting of the Issuer's stockholders occurring after the date of grant. Read SEC document |
| June 08, 2021 Filed Jun 11, 2021 16:07 UTC | Evelo Biosciences, Inc. EVLO · Entity 108468 | GrantStock Option (Right to Buy) · Derivative | 15,690 | $0.00 Strike: $14.60 | $0.00 |
DisclosureSEC source: 0001694665-21-000087 · wf-form4_162344202848304.xml · derivative · entry 1 MELAS KYRIAZI THEO · CIK 0001216078 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,690 Underlying: Common Stock · 15,690 shares Expires 2031-06-07 F1 · derivative.exercise_date: The option vests on the earlier of June 8, 2022 and the day immediately prior to the date of the next annual meeting of the Issuer's stockholders occurring after the date of grant. Read SEC document |
| October 13, 2020 Filed Oct 15, 2020 20:07 UTC | Codiak BioSciences, Inc. CDAK · Entity 114958 | GrantStock Option (Right to Buy) · Derivative | 10,000 | $0.00 Strike: $15.00 | $0.00 |
DisclosureSEC source: 0000899243-20-028412 · doc4.xml · derivative · entry 1 MELAS KYRIAZI THEO · CIK 0001216078 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 10,000 shares Expires 2030-10-12 F1 · derivative.exercise_date: This option shall vest in full upon the earlier to occur of (i) October 13, 2021, and (ii) the next annual meeting of the Issuer's stockholders. Read SEC document |
| October 13, 2020 Filed Apr 30, 2021 16:05 UTC | Codiak BioSciences, Inc. CDAK · Entity 114958 | PurchaseCommon Stock | 6,600 | $15.00 | $99,000.00 |
DisclosureSEC source: 0000899243-21-017623 · doc4.xml · nonDerivative · entry 1 MELAS KYRIAZI THEO · CIK 0001216078 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,600 Read SEC document |
| June 30, 2020 Filed Jul 1, 2020 16:16 UTC | Kaleido Biosciences, Inc. KLDO · Entity 129745 | GrantStock Option (Right to Buy) · Derivative | 15,000 | $0.00 Strike: $7.43 | $0.00 |
DisclosureSEC source: 0001209191-20-039730 · doc4.xml · derivative · entry 1 MELAS KYRIAZI THEO · CIK 0001216078 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,000 Underlying: Common Stock · 15,000 shares Expires 2030-06-29 Read SEC document |
| June 17, 2020 Filed Jun 18, 2020 17:11 UTC | Evelo Biosciences, Inc. EVLO · Entity 108468 | GrantStock Option (Right to Buy) · Derivative | 15,690 | $0.00 Strike: $3.59 | $0.00 |
DisclosureSEC source: 0001694665-20-000057 · wf-form4_159251469917941.xml · derivative · entry 1 MELAS KYRIAZI THEO · CIK 0001216078 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,690 Underlying: Common Stock · 15,690 shares Expires 2030-06-17 F1 · derivative.exercise_date: The option vests on the earlier of June 17, 2021 or the day immediately prior to the date of the next annual meeting of the Issuer's stockholders occurring after the date of grant, in either case subject to the Reporting Person continuing in service on the Issuer's board of directors as a non-employee director through such vesting date. Read SEC document |
| June 04, 2020 Filed Jun 5, 2020 16:06 UTC | Kaleido Biosciences, Inc. KLDO · Entity 129745 | PurchaseCommon Stock | 33,333 | $7.50 | $249,997.50 |
DisclosureSEC source: 0000899243-20-015414 · doc4.xml · nonDerivative · entry 1 MELAS KYRIAZI THEO · CIK 0001216078 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,333 Read SEC document |
| July 31, 2019 Filed Aug 1, 2019 16:30 UTC | Kaleido Biosciences, Inc. KLDO · Entity 129745 | GrantStock Option (Right to Buy) · Derivative | 93,531 | $0.00 Strike: $7.67 | $0.00 |
DisclosureSEC source: 0000899243-19-020827 · doc4.xml · derivative · entry 1 MELAS KYRIAZI THEO · CIK 0001216078 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 93,531 Underlying: Common Stock · 93,531 shares Expires 2029-07-31 F1 · derivative.exercise_date: 33% of this option shall vest on July 11, 2020, with the remainder vesting in 2 equal annual installments thereafter, subject to Mr. Melas-Kyriazi's continued service on the board of directors through each such date. This grant was made in accordance with the Company's Non-Employee Director Compensation Policy. Read SEC document |
| June 12, 2019 Filed Jun 13, 2019 08:14 UTC | Evelo Biosciences, Inc. EVLO · Entity 108468 | GrantStock Option (Right to Buy) · Derivative | 15,690 | $0.00 Strike: $7.07 | $0.00 |
DisclosureSEC source: 0001694665-19-000039 · wf-form4_156042805762009.xml · derivative · entry 1 MELAS KYRIAZI THEO · CIK 0001216078 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,690 Underlying: Common Stock · 15,690 shares Expires 2029-06-12 F1 · derivative.exercise_date: The option vests on the earlier of June 12, 2020 or the day immediately prior to the date of the next annual meeting of the Issuer's stockholders occurring after the date of grant, in either case subject to the Reporting Person continuing in service on the Issuer's board of directors as a non-employee director through each such vesting date. Read SEC document |
| September 16, 2004 Filed Sep 17, 2004 20:50 UTC | THERMO FISHER SCIENTIFIC INC. TMO · Entity 2836 | Exercise / conversionStock Option (Right to Buy) · Derivative | 46,129 | $0.00 Strike: $4.96 | $0.00 |
DisclosureSEC source: 0000097745-04-000157 · mel247.xml · derivative · entry 6 MELAS KYRIAZI THEO · CIK 0001216078 · VP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 46,129 shares Expires 2006-02-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 16, 2004 Filed Sep 17, 2004 20:50 UTC | THERMO FISHER SCIENTIFIC INC. TMO · Entity 2836 | Exercise / conversionStock Option (Right to Buy) · Derivative | 3,139 | $0.00 Strike: $12.74 | $0.00 |
DisclosureSEC source: 0000097745-04-000157 · mel247.xml · derivative · entry 5 MELAS KYRIAZI THEO · CIK 0001216078 · VP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,139 shares Expires 2004-09-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 16, 2004 Filed Sep 17, 2004 20:50 UTC | THERMO FISHER SCIENTIFIC INC. TMO · Entity 2836 | Tax withholdingCommon Stock | 22,148 | $28.20 | $624,573.60 |
DisclosureSEC source: 0000097745-04-000157 · mel247.xml · nonDerivative · entry 3 MELAS KYRIAZI THEO · CIK 0001216078 · VP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 158,199 Read SEC document |
| September 16, 2004 Filed Sep 17, 2004 20:50 UTC | THERMO FISHER SCIENTIFIC INC. TMO · Entity 2836 | Exercise / conversionCommon Stock | 46,129 | $4.96 | $228,799.84 |
DisclosureSEC source: 0000097745-04-000157 · mel247.xml · nonDerivative · entry 2 MELAS KYRIAZI THEO · CIK 0001216078 · VP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 180,347 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 16, 2004 Filed Sep 17, 2004 20:50 UTC | THERMO FISHER SCIENTIFIC INC. TMO · Entity 2836 | Exercise / conversionCommon Stock | 3,139 | $12.74 | $39,990.86 |
DisclosureSEC source: 0000097745-04-000157 · mel247.xml · nonDerivative · entry 1 MELAS KYRIAZI THEO · CIK 0001216078 · VP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 134,218 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 18, 2004 Filed Jun 21, 2004 18:37 UTC | THERMO FISHER SCIENTIFIC INC. TMO · Entity 2836 | SaleCommon Stock | 1,859 | $29.25 | $54,375.75 |
DisclosureSEC source: 0000097745-04-000099 · mel243.xml · nonDerivative · entry 5 MELAS KYRIAZI THEO · CIK 0001216078 · VP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 131,079 Read SEC document |
| June 18, 2004 Filed Jun 21, 2004 18:37 UTC | THERMO FISHER SCIENTIFIC INC. TMO · Entity 2836 | SaleCommon Stock | 5,600 | $29.21 | $163,576.00 |
DisclosureSEC source: 0000097745-04-000099 · mel243.xml · nonDerivative · entry 4 MELAS KYRIAZI THEO · CIK 0001216078 · VP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 132,938 Read SEC document |
| June 18, 2004 Filed Jun 21, 2004 18:37 UTC | THERMO FISHER SCIENTIFIC INC. TMO · Entity 2836 | SaleCommon Stock | 2,200 | $29.13 | $64,086.00 |
DisclosureSEC source: 0000097745-04-000099 · mel243.xml · nonDerivative · entry 3 MELAS KYRIAZI THEO · CIK 0001216078 · VP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 138,538 Read SEC document |
| June 18, 2004 Filed Jun 21, 2004 18:37 UTC | THERMO FISHER SCIENTIFIC INC. TMO · Entity 2836 | SaleCommon Stock | 200 | $29.11 | $5,822.00 |
DisclosureSEC source: 0000097745-04-000099 · mel243.xml · nonDerivative · entry 2 MELAS KYRIAZI THEO · CIK 0001216078 · VP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 140,738 Read SEC document |
| June 18, 2004 Filed Jun 21, 2004 18:37 UTC | THERMO FISHER SCIENTIFIC INC. TMO · Entity 2836 | SaleCommon Stock | 7,600 | $29.06 | $220,856.00 |
DisclosureSEC source: 0000097745-04-000099 · mel243.xml · nonDerivative · entry 1 MELAS KYRIAZI THEO · CIK 0001216078 · VP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 140,938 Read SEC document |
| June 15, 2004 Filed Jun 15, 2004 22:17 UTC | THERMO FISHER SCIENTIFIC INC. TMO · Entity 2836 | Exercise / conversionStock Option (Right to Buy) · Derivative | 33,000 | $0.00 Strike: $20.27 | $0.00 |
DisclosureSEC source: 0000097745-04-000097 · mel239.xml · derivative · entry 19 MELAS KYRIAZI THEO · CIK 0001216078 · VP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,000 Underlying: Common Stock · 33,000 shares Expires 2009-03-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The option vests in three equal annual installments beginning on March 15, 2003. Read SEC document |
| June 15, 2004 Filed Jun 15, 2004 22:17 UTC | THERMO FISHER SCIENTIFIC INC. TMO · Entity 2836 | Exercise / conversionStock Option (Right to Buy) · Derivative | 6,931 | $0.00 Strike: $22.47 | $0.00 |
DisclosureSEC source: 0000097745-04-000097 · mel239.xml · derivative · entry 18 MELAS KYRIAZI THEO · CIK 0001216078 · VP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 6,931 shares Expires 2008-03-14 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The option vests in three equal annual installments beginning on March 14, 2002. Read SEC document |
| June 15, 2004 Filed Jun 15, 2004 22:17 UTC | THERMO FISHER SCIENTIFIC INC. TMO · Entity 2836 | Exercise / conversionStock Option (Right to Buy) · Derivative | 29,074 | $0.00 Strike: $11.50 | $0.00 |
DisclosureSEC source: 0000097745-04-000097 · mel239.xml · derivative · entry 17 MELAS KYRIAZI THEO · CIK 0001216078 · VP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 29,074 shares Expires 2004-10-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 15, 2004 Filed Jun 15, 2004 22:17 UTC | THERMO FISHER SCIENTIFIC INC. TMO · Entity 2836 | GiftCommon Stock | 1,666 | $0.00 | $0.00 |
DisclosureSEC source: 0000097745-04-000097 · mel239.xml · nonDerivative · entry 13 MELAS KYRIAZI THEO · CIK 0001216078 · VP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 148,538 Read SEC document |
| June 15, 2004 Filed Jun 15, 2004 22:17 UTC | THERMO FISHER SCIENTIFIC INC. TMO · Entity 2836 | SaleCommon Stock | 100 | $29.26 | $2,926.00 |
DisclosureSEC source: 0000097745-04-000097 · mel239.xml · nonDerivative · entry 12 MELAS KYRIAZI THEO · CIK 0001216078 · VP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 150,204 Read SEC document |
| June 15, 2004 Filed Jun 15, 2004 22:17 UTC | THERMO FISHER SCIENTIFIC INC. TMO · Entity 2836 | SaleCommon Stock | 900 | $29.29 | $26,361.00 |
DisclosureSEC source: 0000097745-04-000097 · mel239.xml · nonDerivative · entry 11 MELAS KYRIAZI THEO · CIK 0001216078 · VP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 150,304 Read SEC document |
| June 15, 2004 Filed Jun 15, 2004 22:17 UTC | THERMO FISHER SCIENTIFIC INC. TMO · Entity 2836 | SaleCommon Stock | 100 | $29.28 | $2,928.00 |
DisclosureSEC source: 0000097745-04-000097 · mel239.xml · nonDerivative · entry 10 MELAS KYRIAZI THEO · CIK 0001216078 · VP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 151,204 Read SEC document |
| June 15, 2004 Filed Jun 15, 2004 22:17 UTC | THERMO FISHER SCIENTIFIC INC. TMO · Entity 2836 | SaleCommon Stock | 3,400 | $29.32 | $99,688.00 |
DisclosureSEC source: 0000097745-04-000097 · mel239.xml · nonDerivative · entry 9 MELAS KYRIAZI THEO · CIK 0001216078 · VP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 151,304 Read SEC document |
| June 15, 2004 Filed Jun 15, 2004 22:17 UTC | THERMO FISHER SCIENTIFIC INC. TMO · Entity 2836 | SaleCommon Stock | 5,700 | $29.27 | $166,839.00 |
DisclosureSEC source: 0000097745-04-000097 · mel239.xml · nonDerivative · entry 8 MELAS KYRIAZI THEO · CIK 0001216078 · VP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 154,704 Read SEC document |
| June 15, 2004 Filed Jun 15, 2004 22:17 UTC | THERMO FISHER SCIENTIFIC INC. TMO · Entity 2836 | SaleCommon Stock | 39,100 | $29.25 | $1,143,675.00 |
DisclosureSEC source: 0000097745-04-000097 · mel239.xml · nonDerivative · entry 7 MELAS KYRIAZI THEO · CIK 0001216078 · VP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 160,404 Read SEC document |
| June 15, 2004 Filed Jun 15, 2004 22:17 UTC | THERMO FISHER SCIENTIFIC INC. TMO · Entity 2836 | Exercise / conversionCommon Stock | 33,000 | $20.27 | $668,910.00 |
DisclosureSEC source: 0000097745-04-000097 · mel239.xml · nonDerivative · entry 6 MELAS KYRIAZI THEO · CIK 0001216078 · VP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 199,504 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 15, 2004 Filed Jun 15, 2004 22:17 UTC | THERMO FISHER SCIENTIFIC INC. TMO · Entity 2836 | Exercise / conversionCommon Stock | 6,931 | $22.47 | $155,739.57 |
DisclosureSEC source: 0000097745-04-000097 · mel239.xml · nonDerivative · entry 5 MELAS KYRIAZI THEO · CIK 0001216078 · VP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 166,504 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 15, 2004 Filed Jun 15, 2004 22:17 UTC | THERMO FISHER SCIENTIFIC INC. TMO · Entity 2836 | Exercise / conversionCommon Stock | 29,074 | $11.50 | $334,351.00 |
DisclosureSEC source: 0000097745-04-000097 · mel239.xml · nonDerivative · entry 4 MELAS KYRIAZI THEO · CIK 0001216078 · VP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 159,573 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 10, 2004 Filed Jun 15, 2004 22:17 UTC | THERMO FISHER SCIENTIFIC INC. TMO · Entity 2836 | Exercise / conversionStock Option (Right to Buy) · Derivative | 27,375 | $0.00 Strike: $22.47 | $0.00 |
DisclosureSEC source: 0000097745-04-000097 · mel239.xml · derivative · entry 16 MELAS KYRIAZI THEO · CIK 0001216078 · VP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,931 Underlying: Common Stock · 27,375 shares Expires 2008-03-14 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The option vests in three equal annual installments beginning on March 14, 2002. Read SEC document |
| June 10, 2004 Filed Jun 15, 2004 22:17 UTC | THERMO FISHER SCIENTIFIC INC. TMO · Entity 2836 | Exercise / conversionStock Option (Right to Buy) · Derivative | 116,295 | $0.00 Strike: $15.11 | $0.00 |
DisclosureSEC source: 0000097745-04-000097 · mel239.xml · derivative · entry 15 MELAS KYRIAZI THEO · CIK 0001216078 · VP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 116,295 shares Expires 2005-10-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 10, 2004 Filed Jun 15, 2004 22:17 UTC | THERMO FISHER SCIENTIFIC INC. TMO · Entity 2836 | Tax withholdingCommon Stock | 99,874 | $29.84 | $2,980,240.16 |
DisclosureSEC source: 0000097745-04-000097 · mel239.xml · nonDerivative · entry 3 MELAS KYRIAZI THEO · CIK 0001216078 · VP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 130,499 Read SEC document |
| June 10, 2004 Filed Jun 15, 2004 22:17 UTC | THERMO FISHER SCIENTIFIC INC. TMO · Entity 2836 | Exercise / conversionCommon Stock | 27,375 | $22.47 | $615,116.25 |
DisclosureSEC source: 0000097745-04-000097 · mel239.xml · nonDerivative · entry 2 MELAS KYRIAZI THEO · CIK 0001216078 · VP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 230,373 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 10, 2004 Filed Jun 15, 2004 22:17 UTC | THERMO FISHER SCIENTIFIC INC. TMO · Entity 2836 | Exercise / conversionCommon Stock | 116,295 | $15.11 | $1,757,217.45 |
DisclosureSEC source: 0000097745-04-000097 · mel239.xml · nonDerivative · entry 1 MELAS KYRIAZI THEO · CIK 0001216078 · VP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 202,998 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 11, 2004 Filed Feb 13, 2004 22:12 UTC | THERMO FISHER SCIENTIFIC INC. TMO · Entity 2836 | Exercise / conversionStock Option (Right to Buy) · Derivative | 2,780 | $0.00 Strike: $10.78 | $0.00 |
DisclosureSEC source: 0000097745-04-000022 · mel203.xml · derivative · entry 4 MELAS KYRIAZI THEO · CIK 0001216078 · VP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,780 shares Expires 2004-03-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 11, 2004 Filed Feb 13, 2004 22:12 UTC | THERMO FISHER SCIENTIFIC INC. TMO · Entity 2836 | Tax withholdingCommon Stock | 1,706 | $28.56 | $48,723.36 |
DisclosureSEC source: 0000097745-04-000022 · mel203.xml · nonDerivative · entry 2 MELAS KYRIAZI THEO · CIK 0001216078 · VP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 85,461 Read SEC document |
| February 11, 2004 Filed Feb 13, 2004 22:12 UTC | THERMO FISHER SCIENTIFIC INC. TMO · Entity 2836 | Exercise / conversionCommon Stock | 2,780 | $10.78 | $29,968.40 |
DisclosureSEC source: 0000097745-04-000022 · mel203.xml · nonDerivative · entry 1 MELAS KYRIAZI THEO · CIK 0001216078 · VP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 87,167 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 25, 2003 Filed Dec 2, 2003 18:58 UTC | THERMO FISHER SCIENTIFIC INC. TMO · Entity 2836 | GiftCommon Stock | 3,139 | $0.00 | $0.00 |
DisclosureSEC source: 0000097745-03-000183 · mel177.xml · nonDerivative · entry 1 MELAS KYRIAZI THEO · CIK 0001216078 · VP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 84,387 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.